Letters Release of Avastin

Marketing regulations do not apply to individual clinicians

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2071 (Published 21 April 2015) Cite this as: BMJ 2015;350:h2071
  1. Stephen J W Evans, professor of pharmacoepidemiology1
  1. 1Medical Statistics, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
  1. stephen.evans{at}Lshtm.ac.uk

The “licensing” process generally works well to protect patients from drug companies that promote ineffective or unsafe products.1 This regulatory system is not intended to, and should not, regulate clinical practice. In the UK the General Medical Council has applied the industry regulation system to clinical practice, thus …

View Full Text

Sign in

Log in through your institution

Subscribe